The Impact of the Human Papilloma Virus in Pediatric Chronic Kidney Disease, Dialysis, and Transplant Patients

Sponsored by Indiana University

Phase Quota
Phase N/A

The proposed study is a pilot study and a first step towards developing an optimized HPV vaccination strategy for girls who have CKD, or are on dialysis or have a kidney transplant.

Study Start Date: November 2011

Estimated Completion Date: April 2016

Specialties: Nephrology: Chronic Dz/Renal Failure,Dialysis,Peds Nephrology,Transplantation Nursing: Nephrology/Urology Pediatrics: Nephrology/Urology


  • Drug: Human Papillomavirus Vaccine

Inclusion criteria

  • 9-18-year-old girls who have CKD stages 3 or 4 (Glomerular filtration rates 15-59 mL/min/1.73m2)
  • 9-18-year-old girls who are on dialysis
  • 9-18-year-old girls who have had a functioning kidney transplant for longer than 6 months and are on the same immunosuppression regimen
  • Healthy 9-18-year-old girls

Exclusion criteria

  • Pregnancy, fever, allergy to any vaccine component, any immune disorder and any blood product received in the previous 6 months

Study Locations And Contact Information

  • Indiana UniversityRiley Childrens Hospital, Indianapolis Indiana

Feature this Clinical Trial

Get your trial in front of 1000s of physicians and patients.
Visit to find out how you can feature this clinical trial.